Literature DB >> 35665708

PharmGKB summary: acyclovir/ganciclovir pathway.

Maud Maillard1, Li Gong2, Rina Nishii1, Jun J Yang1, Michelle Whirl-Carrillo2, Teri E Klein2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35665708      PMCID： PMC9179945          DOI： 10.1097/FPC.0000000000000474

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN： 1744-6872            Impact factor:   2.000


× No keyword cloud information.
  83 in total

Review 1.  The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation.

Authors:  Camille N Kotton; Deepali Kumar; Angela M Caliendo; Shirish Huprikar; Sunwen Chou; Lara Danziger-Isakov; Atul Humar
Journal:  Transplantation       Date:  2018-06       Impact factor: 4.939

2.  Adverse effects of high-dose intravenous acyclovir in ambulatory patients with acute herpes zoster.

Authors:  B Bean; D Aeppli
Journal:  J Infect Dis       Date:  1985-02       Impact factor: 5.226

3.  In vitro susceptibility of cytomegalovirus isolates from immunocompromised patients to acyclovir and ganciclovir.

Authors:  N L Cole; H H Balfour
Journal:  Diagn Microbiol Infect Dis       Date:  1987-03       Impact factor: 2.803

Review 4.  Acyclovir- and ganciclovir-induced neurotoxicity.

Authors:  M E Ernst; R J Franey
Journal:  Ann Pharmacother       Date:  1998-01       Impact factor: 3.154

Review 5.  Pharmacokinetics, Pharmacodynamics, and Therapeutic Drug Monitoring of Valganciclovir and Ganciclovir in Transplantation.

Authors:  Bénédicte Franck; Julie Autmizguine; Pierre Marquet; Philippe Ovetchkine; Jean-Baptiste Woillard
Journal:  Clin Pharmacol Ther       Date:  2021-11-23       Impact factor: 6.903

6.  Relationship of Ganciclovir Therapeutic Drug Monitoring with Clinical Efficacy and Patient Safety.

Authors:  Brianne M Ritchie; Jason N Barreto; Erin F Barreto; Stacy A Crow; Ross A Dierkhising; Paul J Jannetto; Pritish K Tosh; Raymund R Razonable
Journal:  Antimicrob Agents Chemother       Date:  2019-02-26       Impact factor: 5.191

Review 7.  Mechanism of action and selectivity of acyclovir.

Authors:  G B Elion
Journal:  Am J Med       Date:  1982-07-20       Impact factor: 4.965

8.  Effects of probenecid on the pharmacokinetics and elimination of acyclovir in humans.

Authors:  O L Laskin; P de Miranda; D H King; D A Page; J A Longstreth; L Rocco; P S Lietman
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

9.  Toxicity of 3'-azido-3'-deoxythymidine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for normal human hematopoietic progenitor cells in vitro.

Authors:  J P Sommadossi; R Carlisle
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

10.  Pharmacokinetics of valganciclovir and ganciclovir in renal impairment.

Authors:  David Czock; Cornelia Scholle; Franz Maximilian Rasche; Dieter Schaarschmidt; Frieder Keller
Journal:  Clin Pharmacol Ther       Date:  2002-08       Impact factor: 6.875
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.